TSH Biopharm Corporation Limited Board of Directors resolved to appoint the CFO of the Company. Name, title, and resume of the new position holder:Jung-Liang Kao, Senior Division Director of the Company;Chief Audit Executive of TTY Biopharm Company Limited;Auditor General,CFO, and acting spokesperson of 104 CORPORATION;Senior Director of Audit Department of PwC Taiwan. The newly appointed CFO will take office on April 1, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
60.3 TWD | +2.20% | +10.24% | +19.88% |
Mar. 11 | TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024 | CI |
Mar. 11 | TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+19.88% | 70.98M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 8432 Stock
- News TSH Biopharm Corporation Limited
- TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024